Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation.

Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation... MicroRNA-140 Provides Robustness to the Regulation of Hypertrophic Chondrocyte...